Argatroban TPA Stroke Study [SPOTRIAS] "ARTTS"

Recruiting

Phase N/A Results

Summary of Purpose

Is the combination of low doses of argatroban in combination with rt-PA safe, and does it increase recanalization in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 March 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • The University of Texas Health Science Center, Houston

Trial Design

Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study.

Contacts

  • Loren F. Shen, RN/BSN Phone: 713-500-7084

    loren.shen@uth.tmc.edu